Variability of core microbiota in newly diagnosed treatment-naïve paediatric inflammatory bowel disease patients.
BACKGROUND & AIMS:Intestinal microbiota is considered to play a crucial role in the aetiology of inflammatory bowel disease (IBD). We aimed to describe faecal microbiota composition and dynamics in a large cohort of children with de novo (naïve) IBD, in comparison to healthy paediatric controls...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2018-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC6089417?pdf=render |
| _version_ | 1811322005964718080 |
|---|---|
| author | T G J de Meij E F J de Groot C F W Peeters N K H de Boer C M F Kneepkens A Eck M A Benninga P H M Savelkoul A A van Bodegraven A E Budding |
| author_facet | T G J de Meij E F J de Groot C F W Peeters N K H de Boer C M F Kneepkens A Eck M A Benninga P H M Savelkoul A A van Bodegraven A E Budding |
| author_sort | T G J de Meij |
| collection | DOAJ |
| description | BACKGROUND & AIMS:Intestinal microbiota is considered to play a crucial role in the aetiology of inflammatory bowel disease (IBD). We aimed to describe faecal microbiota composition and dynamics in a large cohort of children with de novo (naïve) IBD, in comparison to healthy paediatric controls (HC). METHODS:In this prospective study, performed at two tertiary centres, faecal samples from newly diagnosed, treatment-naïve paediatric IBD patients were collected prior to bowel cleansing for colonoscopy (t0) and 1, 3 and 6 weeks and 3 months after initiation of therapy. The microbial profiles of Crohn's disease (CD) and Ulcerative colitis (UC) patients were compared with HC and linked to therapeutic response. Microbiota composition was analysed by IS-pro technology. RESULTS:Microbial profiles of 104 new IBD-patients (63 CD, 41 UC, median age 14.0 years) were compared to 61 HC (median 7.8 years). IBD was mainly characterised by decreased abundance of Alistipes finegoldii and Alistipes putredinis, which characterize a healthy state microbial core. The classifier including these core species as predictors achieved an AUC of the ROC curve of .87. Core bacteria tended to regain abundance during treatment, but did not reach healthy levels. CONCLUSION:Faecal microbiota profiles of children with de novo CD and UC can be discriminated from HC with high accuracy, mainly driven by a decreased abundance of species shaping the microbial core in the healthy state. Paediatric IBD can therefore be characterized by decreased abundance of certain bacterial species reflecting the healthy state rather than by the introduction of pathogens. |
| first_indexed | 2024-04-13T13:27:35Z |
| format | Article |
| id | doaj.art-d87d2d68e0ae46c09f8fd401e7c27326 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-04-13T13:27:35Z |
| publishDate | 2018-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-d87d2d68e0ae46c09f8fd401e7c273262022-12-22T02:45:06ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01138e019764910.1371/journal.pone.0197649Variability of core microbiota in newly diagnosed treatment-naïve paediatric inflammatory bowel disease patients.T G J de MeijE F J de GrootC F W PeetersN K H de BoerC M F KneepkensA EckM A BenningaP H M SavelkoulA A van BodegravenA E BuddingBACKGROUND & AIMS:Intestinal microbiota is considered to play a crucial role in the aetiology of inflammatory bowel disease (IBD). We aimed to describe faecal microbiota composition and dynamics in a large cohort of children with de novo (naïve) IBD, in comparison to healthy paediatric controls (HC). METHODS:In this prospective study, performed at two tertiary centres, faecal samples from newly diagnosed, treatment-naïve paediatric IBD patients were collected prior to bowel cleansing for colonoscopy (t0) and 1, 3 and 6 weeks and 3 months after initiation of therapy. The microbial profiles of Crohn's disease (CD) and Ulcerative colitis (UC) patients were compared with HC and linked to therapeutic response. Microbiota composition was analysed by IS-pro technology. RESULTS:Microbial profiles of 104 new IBD-patients (63 CD, 41 UC, median age 14.0 years) were compared to 61 HC (median 7.8 years). IBD was mainly characterised by decreased abundance of Alistipes finegoldii and Alistipes putredinis, which characterize a healthy state microbial core. The classifier including these core species as predictors achieved an AUC of the ROC curve of .87. Core bacteria tended to regain abundance during treatment, but did not reach healthy levels. CONCLUSION:Faecal microbiota profiles of children with de novo CD and UC can be discriminated from HC with high accuracy, mainly driven by a decreased abundance of species shaping the microbial core in the healthy state. Paediatric IBD can therefore be characterized by decreased abundance of certain bacterial species reflecting the healthy state rather than by the introduction of pathogens.http://europepmc.org/articles/PMC6089417?pdf=render |
| spellingShingle | T G J de Meij E F J de Groot C F W Peeters N K H de Boer C M F Kneepkens A Eck M A Benninga P H M Savelkoul A A van Bodegraven A E Budding Variability of core microbiota in newly diagnosed treatment-naïve paediatric inflammatory bowel disease patients. PLoS ONE |
| title | Variability of core microbiota in newly diagnosed treatment-naïve paediatric inflammatory bowel disease patients. |
| title_full | Variability of core microbiota in newly diagnosed treatment-naïve paediatric inflammatory bowel disease patients. |
| title_fullStr | Variability of core microbiota in newly diagnosed treatment-naïve paediatric inflammatory bowel disease patients. |
| title_full_unstemmed | Variability of core microbiota in newly diagnosed treatment-naïve paediatric inflammatory bowel disease patients. |
| title_short | Variability of core microbiota in newly diagnosed treatment-naïve paediatric inflammatory bowel disease patients. |
| title_sort | variability of core microbiota in newly diagnosed treatment naive paediatric inflammatory bowel disease patients |
| url | http://europepmc.org/articles/PMC6089417?pdf=render |
| work_keys_str_mv | AT tgjdemeij variabilityofcoremicrobiotainnewlydiagnosedtreatmentnaivepaediatricinflammatoryboweldiseasepatients AT efjdegroot variabilityofcoremicrobiotainnewlydiagnosedtreatmentnaivepaediatricinflammatoryboweldiseasepatients AT cfwpeeters variabilityofcoremicrobiotainnewlydiagnosedtreatmentnaivepaediatricinflammatoryboweldiseasepatients AT nkhdeboer variabilityofcoremicrobiotainnewlydiagnosedtreatmentnaivepaediatricinflammatoryboweldiseasepatients AT cmfkneepkens variabilityofcoremicrobiotainnewlydiagnosedtreatmentnaivepaediatricinflammatoryboweldiseasepatients AT aeck variabilityofcoremicrobiotainnewlydiagnosedtreatmentnaivepaediatricinflammatoryboweldiseasepatients AT mabenninga variabilityofcoremicrobiotainnewlydiagnosedtreatmentnaivepaediatricinflammatoryboweldiseasepatients AT phmsavelkoul variabilityofcoremicrobiotainnewlydiagnosedtreatmentnaivepaediatricinflammatoryboweldiseasepatients AT aavanbodegraven variabilityofcoremicrobiotainnewlydiagnosedtreatmentnaivepaediatricinflammatoryboweldiseasepatients AT aebudding variabilityofcoremicrobiotainnewlydiagnosedtreatmentnaivepaediatricinflammatoryboweldiseasepatients |